These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 30691475)

  • 21. Overexpression of Trps1 contributes to tumor angiogenesis and poor prognosis of human osteosarcoma.
    Li Z; Jia M; Wu X; Cui J; Pan A; Li L
    Diagn Pathol; 2015 Sep; 10():167. PubMed ID: 26377811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NPRL2 is an independent prognostic factor of osteosarcoma.
    Gao Y; Wang J; Fan G
    Cancer Biomark; 2012-2013; 12(1):31-6. PubMed ID: 23321467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of MMP-2 expression and prognosis in osteosarcoma patients.
    Zhang M; Zhang X
    Int J Clin Exp Pathol; 2015; 8(11):14965-70. PubMed ID: 26823829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic role of the recepteur d'origine nantais (RON) expression in primary high-grade osteosarcoma.
    Wang SL; Weng DF; Wei HX; Huang Z; Lin RQ; Shi K; Lin JH
    J Orthop Sci; 2021 Nov; 26(6):1100-1106. PubMed ID: 32972820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High expression of metabotropic glutamate receptor 4: correlation with clinicopathologic characteristics and prognosis of osteosarcoma.
    Yang W; Maolin H; Jinmin Z; Zhe W
    J Cancer Res Clin Oncol; 2014 Mar; 140(3):419-26. PubMed ID: 24399291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma.
    Wang Z; Cai H; Lin L; Tang M; Cai H
    Pediatr Blood Cancer; 2014 Feb; 61(2):206-10. PubMed ID: 24038809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathological and prognostic values of ErbB receptor family amplification in primary osteosarcoma.
    Huang Z; Wang SL; Chen H; Shen RK; Li XD; Huang QS; Wu CY; Weng DF; Lin JH
    Scand J Clin Lab Invest; 2019 Dec; 79(8):601-612. PubMed ID: 31663373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Multivariate analysis for prognostic factors among 43 patients with osteosarcoma].
    Zhang B; Pang QJ; Zhang HJ; Yuan Y
    Zhongguo Gu Shang; 2011 Dec; 24(12):982-6. PubMed ID: 22276503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-21 predicts poor prognosis in patients with osteosarcoma.
    Ren X; Shen Y; Zheng S; Liu J; Jiang X
    Br J Biomed Sci; 2016 Oct; 73(4):158-162. PubMed ID: 27922432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathological and prognostic value of NADPH oxidase 2 (NOX2) in primary osteosarcoma.
    Lin RJ; Huang Z; Wang SL; Chen H; Wei HX; Shen RK; Yang LY; Lin JH
    J Orthop Sci; 2021 May; 26(3):466-472. PubMed ID: 32402505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interferon-α/β receptor as a prognostic marker in osteosarcoma.
    Kubo T; Shimose S; Matsuo T; Fujimori J; Arihiro K; Ochi M
    J Bone Joint Surg Am; 2011 Mar; 93(6):519-26. PubMed ID: 21411701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy.
    Robl B; Pauli C; Botter SM; Bode-Lesniewska B; Fuchs B
    BMC Cancer; 2015 May; 15():379. PubMed ID: 25956431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclooxygenase-2 overexpression predicts poor survival in patients with high-grade extremity osteosarcoma: a pilot study.
    Urakawa H; Nishida Y; Naruse T; Nakashima H; Ishiguro N
    Clin Orthop Relat Res; 2009 Nov; 467(11):2932-8. PubMed ID: 19326179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated expression of microRNA-19a predicts a poor prognosis in patients with osteosarcoma.
    Zou P; Ding J; Fu S
    Pathol Res Pract; 2017 Mar; 213(3):194-198. PubMed ID: 28214202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. pFAK-Y397 overexpression as both a prognostic and a predictive biomarker for patients with metastatic osteosarcoma.
    Thanapprapasr K; Nartthanarung A; Thanapprapasr D; Jinawath A
    PLoS One; 2017; 12(8):e0182989. PubMed ID: 28846700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased expression of STAT5A predicts poor prognosis in osteosarcoma.
    Guo Z; Tang Y; Fu Y; Wang J
    Pathol Res Pract; 2019 Mar; 215(3):519-524. PubMed ID: 30638860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinicopathologic significance of S100A4 expression in osteosarcoma.
    Cao CM; Yang FX; Wang PL; Yang QX; Sun XR
    Eur Rev Med Pharmacol Sci; 2014; 18(6):833-9. PubMed ID: 24706307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of bax, cytochrome C, and caspase-8 protein expression in primary osteosarcoma.
    Kaseta MK; Gomatos IP; Khaldi L; Tzagarakis GP; Alevizos L; Themistocleous GS; Leandros E; Soucacos PN
    Hybridoma (Larchmt); 2007 Dec; 26(6):355-62. PubMed ID: 18158779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of microRNA-223/epithelial cell transforming sequence 2 signaling in patients with osteosarcoma.
    Zhang H; Yin Z; Ning K; Wang L; Guo R; Ji Z
    Hum Pathol; 2014 Jul; 45(7):1430-6. PubMed ID: 24784921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased expression of insulin-like growth factor-1 receptor is correlated with tumor metastasis and prognosis in patients with osteosarcoma.
    Wang YH; Han XD; Qiu Y; Xiong J; Yu Y; Wang B; Zhu ZZ; Qian BP; Chen YX; Wang SF; Shi HF; Sun X
    J Surg Oncol; 2012 Mar; 105(3):235-43. PubMed ID: 21866554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.